Adipocytokine profile in children with Kawasaki disease

Beuy Joob1, Viroj Wiwanitkit2

  • 1Medical Center, Sanitation Medical Academic Center, Bangkok 10203043, Thailand. beuyjoob@hotmail.com.

Insights

This study examines adipocytokine profiles in children with Kawasaki disease, raising concerns about potential confounding factors influencing the results.

Area of Science:

  • Pediatrics
  • Immunology
  • Biochemistry

Background:

  • Kawasaki disease is an acute febrile illness affecting young children.
  • Adipocytokines play a role in inflammation and immune responses.
  • Previous studies have explored adipocytokine profiles in Kawasaki disease.

Purpose of the Study:

  • To critically evaluate a recent publication on adipocytokine profiles in pediatric Kawasaki disease.
  • To identify and discuss potential confounding factors that may affect the interpretation of adipocytokine data.

Main Methods:

  • Review and critical analysis of existing literature.
  • Discussion of potential confounding variables in pediatric research.

Main Results:

  • Concerns regarding the methodology and interpretation of adipocytokine profiles in the discussed publication.
  • Identification of key confounding factors such as age, nutritional status, and treatment protocols.

Conclusions:

  • The interpretation of adipocytokine profiles in Kawasaki disease requires careful consideration of confounding factors.
  • Further research with robust control for confounders is needed to elucidate the role of adipocytokines.

Related Concept Videos

Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
48
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
55
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
53
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
53
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.1K